Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival
Links shared publicly online about this topic.
- 249total visits
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival
View full resource at medicalnewstoday.com
Tags: Vaccination, Cancer, Skin Cancer, Melanoma, Drug, Vaccine
Most Recently Shared on June 2, 2011 at 7:05 am By:
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival http://mnt.to/3WDc #skincancer #melanoma
Also Shared By:
Vaccine first to show improved survival rates for metastatic melanoma
labspaces.net — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.” View full resource at labspaces.net
Most Recently Shared on June 6, 2011 at 1:15 pm By:
Vaccine first to show improved survival rates for metastatic melanoma - http://is.gd/AR64mY
Vaccine First to Show Improved Survival Rates for Metastatic Melanoma
newswise.com — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2can improve response rate and progression-free survival.” View full resource at newswise.com
Most Recently Shared on June 3, 2011 at 9:01 pm By:
#health news: Vaccine First to Show Improved Survival Rates for Metastatic Melanoma: For patients with advanced ... http://bit.ly/kVz7nd
Vaccine First to Show Improved Survival Rates for Metastatic Melanoma
newswise.com — “For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2can improve response rate and progression-free survival.” View full resource at newswise.com
Most Recently Shared on June 3, 2011 at 8:22 pm By:
newswise Health Communicator and Health News
Vaccine First to Show Improved Survival Rates for Metastatic Melanoma: For patients with advanced melanoma, whic... http://bit.ly/jbtdHy
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival - QualityPoint Technologies
qualitypointtech.net — “A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care. The findings, published in the June 2 New England Journal of Medicine, mark the first vaccine study in the disease - and one of the first in cancer over” View full resource at qualitypointtech.net
Most Recently Shared on June 2, 2011 at 9:00 am By:
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival: A vaccine for one of the most leth... http://bit.ly/jWrehL
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival
newswise.com — “First cancer vaccine to show improved response rate.” View full resource at newswise.com
Most Recently Shared on June 1, 2011 at 9:31 pm By:
newswise Health Communicator and Health News
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival: First cancer ... http://bit.ly/jBDj1b | register to view
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival
newswise.com — “First cancer vaccine to show improved response rate.” View full resource at newswise.com
Most Recently Shared on June 1, 2011 at 9:29 pm By:
#health news: Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival: First cancer vacci... http://bit.ly/ijugKf
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival
newswise.com — “First cancer vaccine to show improved response rate.” View full resource at newswise.com
Most Recently Shared on June 1, 2011 at 9:18 pm By:
newswise Health Communicator and Health News
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival: First cancer vaccine to show imp... http://bit.ly/lT8olM
Interleukin-2 shows promise against advanced melanoma
news-medical.net — “A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.” View full resource at news-medical.net
Most Recently Shared on June 1, 2009 at 8:50 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Interleukin-2 shows promise against advanced melanoma: A vaccine for one of the mos.. http://cli.gs/SNqt6U
Vaccine Shows Therapeutic Promise Against Advanced Melanoma - MD Anderson Cancer Center
mdanderson.org — “A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.” View full resource at mdanderson.org
Most Recently Shared on June 1, 2009 at 5:20 pm By:
Vaccine Shows Therapeutic Promise Against Advanced Melanoma http://is.gd/LDZw
Vaccine Shows Therapeutic Promise Against Advanced Melanoma
newswise.com — “A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.” View full resource at newswise.com
Most Recently Shared on May 30, 2009 at 9:50 pm By:
Vaccine Shows Therapeutic Promise Against Advanced Melanoma http://bit.ly/MQzrh
Advertisement
MNT Vaccines
@mnt_vaccines
Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival http://mnt.to/3WDc #vaccines #immunesystem
1 year ago...